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summary of mean and minimum percentage of detectors/pixels 
passing with γ<1 is given in Table 1 for 3%/3mm, 3%/2mm and 
2%/2mm for each system. A lower number indicates greater 
measurement sensitivity. Additionally, ρc, is given for the comparison 
between measured and predicted γ for each system in Table 1. The 
Delta4 was found to be the most sensitive system overall but with the 
lowest ρc, indicating lower agreement with the predicted γ. The 
remaining systems had comparable sensitivity to each other. The 2D-
Array and ArcCHECK measurements exhibited better statistical 
agreement with the predicted γ.  
Conclusions: It is important to understand the sensitivity and 
limitations of the gamma index analysis combined with the equipment 
in use. For the same passing criteria, different devices and software 
combinations exhibit varying sensitivity and agreement with the 
predicted analysis.  
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Purpose/Objective: The use of volumetric arc therapy (VMAT) is 
growing rapidly for many radio-therapy treatments due to its ability to 
quickly deliver highly conformal dose distributions. There has also 
been an increasing interest to use high dose rate flattening filter free 
(FFF) beams as inverse planning systems do not require flat, evenly 
distributed beams. Such fast and complex treatments should be 
accompanied by robust verification. Methods to calibrate electronic 
portal imaging device (EPID) dosimetry has been previously 
documented for step and shoot stereotactic treatments such as 
Intensity modulated radiotherapy (IMRT) using only flattened beams 
and only on the integrated fraction or beam. The aim of this work is 
to provide a time-dependent dose verification method for VMAT that 
can be used with flattened or FFF pre-treatment beams via a general 
calibration model for amorphous silicon (a-Si) EPIDs. 
Materials and Methods: The general calibration model was created 
using a Varian Truebeam, equipped with an as1000 EPID, for each 
unique energy spectrum 6MV, 10MV, 6MV-FFF, 10MV-FFF taking the 
field size, off axis ratio, and penumbral spectral changes of the beam 
into account. Also included in the model are the EPID specific 
corrections such as pixel sensitivity, support arm back scatter, and 
image ghosting. As planned VMAT treatments are separated into 
control points (CPs) for optimization, measured images are also 
separated into the same time intervals so that direct verification of 
prediction images can be performed. Linac log files were used to 
synchronize measurement and prediction. The dosimetric accuracy of 
the calibration model was determined for a range of treatment 
conditions. Measured and predicted 2D control point doses were 
compared using a gamma evaluation with criterion of 3% 3mm. 
Results: Out of 20 VMAT plans tested that passed the clinical action 
level for integrated dose (95% in field area with gamma within 3% 
3mm), the poorest performing plan contained 4.2% in-field area failing 
the gamma criterion when delivered with a flattened beam and 4.0% 
when delivered with a FFF beam. The same plan analysed per control 
point revealed that 18%, and 17% of the arc contained failure areas 
larger than 5% when delivered with a flattened and FFF beam 
respectively. Analysing VMAT treatments per control point reveals 
deviations from predictions during the arc that are averaged in 
integrated doses, and therefore undetectable. For repeated deliveries 
of the same plan, the highest dose variation in delivery of FFF plans 
was ~0.5% compared to 0.2% for flattened beams.  
 
 
Conclusions: The EPID calibration model allows verification of pre-
treatment VMAT doses for both flattened and unflattened beams in a 
time-dependent manner.  
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Purpose/Objective: To develop a method for pre-treatment 
verification of VMAT dose delivery as a function of gantry angle using 
an EPID. 
Materials and Methods: The method: 1) compares MV EPID image 
frames with predicted images at the delivered gantry angles; 2) uses 
an accurate physics-based model that models the EPID images from 
the planned MLC motions and gantry angles; 3) acquires EPID image 
frames using an ancillary frame-grabber system that captures all 
acquired image frames without frame loss; 4) determines the gantry 
angle for the MV image from an accurate encoder-derived gantry 
angle tagged to the header of kV frames (acquired simultaneously 
with the frame-grabber); 5) accounts for small variations in delivered 
gantry angle by a search of a small sub-arc of angles centred on the 
imaged angle to synchronise the measured and predicted images; and 
6) performs Chi comparison of measured and predicted images giving 
these analyses as a function of gantry angle. The method also 
classifies images without significant signal due to beam-holds from 
low signal images using the scatter signal to the kV imager, and we 
have optimised the acquisition frame-rate to reduce image artefact 
due to beam pulse dropping during VMAT delivery. 
Results: The physics-based model was tested for agreement with EPID 
images integrated over the entire treatment with average Chi pass 
rates at 2%,2mm of 99.2% (10% threshold). The accuracy of the gantry 
angle method was tested using images of a phantom to encode the 
true angle on the MV image, with agreement (1 SD) of 0.1 degrees. Chi 
analysis results as a function of angle were assessed for 10 prostate 
patient deliveries. Approximately 650 images were captured during 
each arc delivery, resulting in ~ 100 Chi maps, each representing a 3.5 
degree sub-arc. All Chi pass-rates were greater than 90% at 3%,3mm 
criteria for these images, and more than 90% have a 95% pass-rate, 
  
 
 
 
 
 
 
 
 
 
 
 
 
